Effects of Treatment With Aprepitant (Emend®) in HIV Infected Individuals. 375 mg Dose

NCT01300988 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

18

Enrollment

OTHER

Sponsor class

Conditions

HIV Infection

Interventions

DRUG: Aprepitant
DRUG: Aprepitant placebo

Sponsor

University of Pennsylvania

Collaborators

[object Object]